Unknown

Dataset Information

0

HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease.


ABSTRACT: OBJECTIVES:We investigated the associations with HLA and microtubule-associated protein tau (MAPT) H1 haplotype in anti-IgLON5 disease, a recently identified disorder characterized by gait instability, brainstem dysfunction, and a prominent sleep disorder in association with IgLON5 antibodies and pathologic findings of a novel neuronal-specific tauopathy. METHODS:We compared the HLA alleles and MAPT H1/H1 genotype of 35 patients with anti-IgLON5 with healthy controls. The on-line server tool NetMHCIIpan 3.1 was used to predict the IgLON5 peptide binding to HLA Class II molecules. RESULTS:The HLA-DRB1*10:01-DQB1*05:01 haplotype was overrepresented in patients with anti-IgLON5 disease (OR = 54.5; 95% CI: 22.2-133.9, p < 0.0001). In addition, HLA-DQA was genotyped in 27 patients, and 25 (92.6%) of them had DQ molecules composed by DQA1*01 and DQB1*05 chains compared with 148/542 (27.3%) controls (OR = 43.9; 95% CI: 10.4-185.5, p < 0.0001). Patients DRB1*10:01 positive developed more frequently sleep or bulbar symptoms than those carrying other HLA alleles (70.0% vs 26.7%; p = 0.011). Prediction algorithms identified 2 IgLON5 peptides (1 located in the signal sequence) that showed strong binding to HLA-DRB1*10:01 and other HLA-DRB1, but not to HLA-DQA and HLA-DQB molecules. The MAPT H1/H1 homozygous genotype was present in 20/24 (83.3%) anti-IgLON5 Caucasian patients compared with 54/116 (46.5%) healthy controls (p = 0.0007). CONCLUSIONS:The robust association of anti-IgLON5 disease with distinct HLA Class II molecules supports a primary autoimmune origin. The significant association of MAPT H1 haplotype also suggests that an underlying neurodegenerative process could be involved in anti-IgLON5 disease.

SUBMITTER: Gaig C 

PROVIDER: S-EPMC6705627 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease.

Gaig Carles C   Ercilla Guadalupe G   Daura Xavier X   Ezquerra Mario M   Fernández-Santiago Ruben R   Palou Eduard E   Sabater Lidia L   Höftberger Romana R   Heidbreder Anna A   Högl Birgit B   Iranzo Alex A   Santamaria Joan J   Dalmau Josep J   Graus Francesc F  

Neurology(R) neuroimmunology & neuroinflammation 20190812 6


<h4>Objectives</h4>We investigated the associations with HLA and microtubule-associated protein tau (<i>MAPT</i>) H1 haplotype in anti-IgLON5 disease, a recently identified disorder characterized by gait instability, brainstem dysfunction, and a prominent sleep disorder in association with IgLON5 antibodies and pathologic findings of a novel neuronal-specific tauopathy.<h4>Methods</h4>We compared the HLA alleles and <i>MAPT</i> H1/H1 genotype of 35 patients with anti-IgLON5 with healthy controls  ...[more]

Similar Datasets

| S-EPMC4057305 | biostudies-literature
| S-EPMC2709887 | biostudies-literature
| S-EPMC2396711 | biostudies-literature
| S-EPMC3827724 | biostudies-literature
| S-EPMC4815063 | biostudies-literature
| S-EPMC3724453 | biostudies-literature
| S-EPMC5341865 | biostudies-literature
| S-EPMC8794918 | biostudies-literature
| S-EPMC9825173 | biostudies-literature
| S-EPMC10073962 | biostudies-literature